“From 25 to 30 million healthy, middle-aged Americans are at far higher risk than they and their doctors understand them to be, because we’re not taking inflammatory factors into account.” ‘An inexpensive blood test for a protein linked to artery disease may be better than a cholesterol test at predicting a person’s risk for a heart attack or stroke, researchers are reporting today.
The test, for the substance, C-reactive protein, may help identify people who have an increased risk even though they do not have high cholesterol. About half of the people with heart disease have normal cholesterol levels, a finding that has led many researchers to suspect that other factors must play a role in cardiovascular disease.’ The large study, reported in this week’s New England Journal of Medicine, showed that high CRP levels correlated much better with cardiovascular morbidity and mortality than the lipid studies on which we currently rely.
Many researchers think chronic inflammation plays a major part in artery disease, heart attacks and strokes. Inflammation inside arteries is thought to contribute to heart attacks and strokes by causing cholesterol deposits in the artery walls to rupture and bleed. Blood clots then form, blocking the vessels and cutting off the blood supply to portions of the heart or brain.
C-reactive protein, Dr. Topol said, “is a window into the process of arterial inflammation, a very important insight that we otherwise can’t get.”
Yet, it is unclear yet if lowering a concerning CRP level will decrease cardiovascular risks. NY Times
